Brief: Rubra Medicaments approves re-appointment of Atul Anand as MD
Aug 10 (Reuters) - Rubra Medicaments Ltd RUBR.BO
* Says approves re-appointment of Abha Kapoor as director
(finance) & chief financial officer of the company
* Says approves re-appointment of Atul Anand as managing
director of the company
* Says approves increase in authorized share capital of the
company INR 82 million
Source text - http://bit.ly/2wwbW1X
Further company coverage: RUBR.BO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Checkpoint Trends
See all newsBrief: Checkpoint Trends To Evaluate Revised Proposal For Raising Funds
Brief: Checkpoint Trends Says Abha Rajesh Kapoor Resigns As Whole-Time Director And CFO
Brief: Checkpoint Trends Approves Issue Of Equity Shares Through QIP For 5 Billion Rupees
Brief: Rubra Medicaments Gets Shareholders' Nod For Appointment Of Sunil Khandalwal As MD
Brief: Rubra Medicaments' MD Atul Anand Resigns